Congenital Cervical Spine Stenosis in a Multicenter Global Cohort of Patients With Degenerative Cervical Myelopathy: An Ambispective Report Based on a Magnetic Resonance Imaging Diagnostic Criterion.
Fuente
Este artículo es publicado originalmente en:
https://www.ncbi.nlm.nih.gov/pubmed/29462433
https://academic.oup.com/neurosurgery/advance-article-abstract/doi/10.1093/neuros/nyx521/4865207?redirectedFrom=fulltext
De:
Nouri A1,2, Tetreault L1, Nori S1, Martin AR1, Nater A1, Fehlings MG1.
Neurosurgery. 2018 Feb 16. doi: 10.1093/neuros/nyx521. [Epub ahead of print]
Todos los derechos reservados para:
Abstract
BACKGROUND:
Congenital spinal stenosis (CSS) of the cervical spine is a risk factor for acute spinal cord injury and development of degenerative cervical myelopathy (DCM).
OBJECTIVE:
To develop magnetic resonance imaging (MRI)-based criteria to diagnose preexisting CSS and evaluate differences between patients with and without CSS.
CONCLUSION:
SCOR ≥ 70% is an effective criterion to diagnose CSS. CSS patients develop myelopathy at a younger age and have greater impairment and disability than other patients with DCM. Despite this, CSS patients have comparable duration of symptoms, MRI presentations, and surgical outcomes to DCM patients without CSS.
Advance Access Article on the blog today: Congenital Cervical Spine Stenosis in a Multicenter Global Cohort of Patients With Degenerative Cervical Myelopathy: An Ambispective Report Based on a Magnetic Resonance Imaging Diagnostic Criterion https://t.co/LfY1933zcq pic.twitter.com/IDfZhf8cCv
— NEUROSURGERY Journal (@NeurosurgeryCNS) 20 de febrero de 2018
Resumen
ANTECEDENTES:
La estenosis espinal congénita (CSS) de la columna cervical es un factor de riesgo de lesión aguda de la médula espinal y desarrollo de mielopatía cervical degenerativa (MCD).
OBJETIVO:
Desarrollar criterios basados en imágenes de resonancia magnética (MRI) para diagnosticar CSS preexistentes y evaluar las diferencias entre pacientes con y sin CSS.
CONCLUSIÓN:
SCOR ≥ 70% es un criterio efectivo para diagnosticar CSS. Los pacientes de CSS desarrollan mielopatía a una edad más temprana y tienen un mayor deterioro y discapacidad que otros pacientes con DCM. A pesar de esto, los pacientes de CSS tienen una duración comparable de síntomas, presentaciones de MRI y resultados quirúrgicos para pacientes DCM sin CSS.
